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Mycobacterium bovis is endemic in Michigan’s white-
tailed deer and has been circulating since 1994. The strain 
circulating in deer has remained genotypically consistent 
and was recently detected in 2 humans. We summarize the 
investigation of these cases and conﬁ  rm that recreational 
exposure to deer is a risk for infection in humans.
H
istorically, Mycobacterium bovis infection in humans 
was associated with consumption of unpasteurized 
milk and dairy products (1,2) and this is still the most 
important route of exposure in developing countries. US 
populations are exposed to unpasteurized dairy products 
imported from countries where M. bovis is prevalent (3,4). 
M. bovis infection in humans is of concern to health ofﬁ  -
cials in Michigan because of to its endemicity in the state’s 
wild white-tailed deer population and its discovery in sev-
eral cattle herds. M. bovis in deer represents possible oc-
cupational and recreational routes of exposure to humans, 
especially for hunters, trappers, taxidermists, venison pro-
cessors, and venison consumers (5).
Although M. bovis is a zoonotic agent, surveillance in-
dicates no increase in its incidence in Michigan residents 
since an outbreak began in 1994. Since 1995, the inci-
dence rate of M. bovis infection in Michigan residents has 
remained very low, with ≈1 new case per year for a total 
of 13. No genetic or epidemiologic link to the deer/cattle 
outbreak strain has been identiﬁ  ed among 11 of these hu-
man M. bovis cases, based on restriction fragment-length 
polymorphism analysis, spoligotyping, or mycobacterial 
interspersed repeat units (MIRU) typing (M. Wilkins, un-
pub. data, Michigan Department of Community Health, 
March 2007). Table 1 shows the spoligotyping and MIRU 
typing results from 9 available human specimens that were 
unrelated to the deer/cattle outbreak strain. All genotyping 
of isolates mentioned in this report was performed at the 
Michigan Department of Community Health, Bureau of 
Laboratories, Lansing, MI, USA, by using currently rec-
ommended guidelines (Centers for Disease Control and 
Prevention, Atlanta, GA, USA) (8–10). The remaining 2 
human cases of M. bovis occurred in US-born, Michigan 
residents; the cases had epidemiologic and molecular links 
to the genotypically consistent deer/cattle outbreak strain 
circulating in Michigan.
The Cases
Patient 1, 2002
In January 2002, a 74-year-old man sought medical care, 
reporting malaise, anorexia, and fever. Past medical history 
included ischemic bowel disease, vascular disease, partial 
gastrectomy for peptic ulcers, and left upper lobectomy for 
squamous cell carcinoma (December 1999). On February 
1, he was hospitalized with persistent fever and nonproduc-
tive cough; results of a chest radiograph were consistent 
with necrotizing pneumonia. A tuberculosis (TB) skin test 
(TST) result was negative, and a sputum smear was nega-
tive for acid-fast bacilli (AFB). After 5 days, the patient 
had not improved clinically; chest radiograph showed in-
creasing inﬁ  ltrate on the left side. Diagnostic bronchoscopy 
was performed, which yielded an AFB-positive smear. The 
condition of the patient deteriorated clinically over the next 
10 days; he died on day 16 of his hospitalization.
Laboratory conﬁ  rmation for TB, speciation, and anti-
microbial drug susceptibility testing were pending at the 
time of his death. Genotyping analysis showed that the M. 
bovis isolated from this patient matched the circulating 
deer/cattle strain (Table 2).
In his youth, patient 1 lived on a farm geographically 
distant from the current bovine TB–endemic area. His ﬁ  rst 
wife had a reported diagnosis of TB after their divorce >40 
years before, and his second wife reports he drank unpas-
teurized milk as a youth. He moved to the edge of Deer 
Management Unit (DMU) 452 in 1994, which is the focal 
area for the bovine TB outbreak in deer. There, he ran a 
business with a buck pole where hunters displayed killed 
deer. Additional potential exposures included hunting 
white-tailed deer and consuming venison (>10 years before 
his death), handling a deer carcass from the DMU 452 vi-
cinity in 2000, and recreational feeding of deer.
This patient was in poor health at the time of death, 
having acute and chronic illness. His poor health would 
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bovis and would have made the progression from latent 
infection to clinical disease more likely. The pathology 
results from his lung resection in December 1999 provid-
ed no evidence of TB; therefore, infection was likely ac-
quired subsequently. The genotyping results from patient 
1 matched those of the circulating deer/cattle strain, which 
suggested exposure to infected cattle or deer. The lack of 
recent exposure to cattle suggests that deer are the more 
likely source of infection.
Patient 2, 2004
Patient 2 was a 29-year-old, previously healthy man. 
On October 1, 2004, he shot a white-tailed deer just outside 
DMU 452. While ﬁ  eld dressing the animal, he punctured 
his left index ﬁ  nger with a hunting knife. Approximately 18 
days after the injury, his ﬁ  nger became inﬂ  amed and pain-
ful, so he sought medical treatment. Based on his history of 
exposure to a deer with lesions, a TST was administered; 
the result was negative. After ≈10 days of antimicrobial 
drug therapy, the wound had not improved. He was hospi-
talized, and the infected ﬁ  nger was incised and drained. An 
orthopedic specialist diagnosed infectious tenosynovitis of 
the ﬂ  exor tendon of the left index ﬁ  nger. The initial slide 
preparation was negative for AFB. A wound culture was 
sent to Michigan Department of Community Health, Bu-
reau of Laboratories. 
The patient was discharged and then readmitted to 
the hospital 12 days later with subcutaneous infection at 
the puncture site, which was again incised and drained. A 
slide made of growth from the broth culture medium was 
positive for AFB. Genetic probe results conﬁ  rmed M. tu-
berculosis complex. By December 7, 2004, the culture was 
reported as resistant to pyrazinamide, suggesting M. bovis, 
which was later conﬁ  rmed on the basis of susceptibility to 
thiopene-2-carboxyikic acid hydrazide and biochemical 
testing for pyrazinamidase. The result of a second skin test, 
14 weeks postexposure, was positive (6-mm induration). 
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Table 1. Nonepidemiologically linked human Mycobacterium bovis spoligotyping and MIRU typing results for 9 available human 
specimens, Michigan* 
Country of 
birth Site
Year 
collected
International
spoligotype†  MIRU type  Spoligotypes
USA Cervical
LN
1997 SB1210 Not available  Ɠ Ɠ ƓƓ  ƓƓƓƓ   Ɠ                  
    ƓƓƓƓƓ 
USA Spine 1997 SB0131 Not available    Ɠ Ɠ   Ɠ Ɠ    Ɠ                
      ƓƓƓƓƓ 
Mexico Abd
abscess
1998 SB0140 232224152322    Ɠ  Ɠ ƓƓƓƓƓ   Ɠ                 
     ƓƓƓƓƓ 
Mexico Sputum 1998 SB1210 Not available  Ɠ Ɠ ƓƓ  ƓƓƓƓ   Ɠ                  
    ƓƓƓƓƓ 
Bosnia Cervical 
LN
2000 SB1215 232314353312    Ɠ    ƓƓƓƓƓ Ɠ Ɠ                 
     ƓƓƓƓƓ 
Mexico Sputum 2003 SB0121 232314223322    Ɠ     Ɠ      Ɠ    Ɠ          
       ƓƓƓƓƓ 
USA Cervical
LN
2003 SB0121 232324252322    Ɠ     Ɠ      Ɠ    Ɠ          
       ƓƓƓƓƓ 
Mexico Cervical
LN
2005 SB1216 232124233222  ƓƓƓ     Ɠ Ɠ    Ɠ           ƓƓƓ    
    ƓƓƓƓƓ 
Mexico Cervical
LN
2007 SB0140 231224243322    Ɠ  Ɠ ƓƓƓƓƓ   Ɠ                 
     ƓƓƓƓƓ 
*MIRU, mycobacterial interspersed repeat units (6); LN, lymph node; Abd, abdominal. 
†International Spoligotype Database, available from www.mbovis.org (7). 
Table 2. Epidemiologically linked Mycobacterium bovis spoligotyping and MIRU typing results, Michigan* 
Species
Year 
collected
International
spoligotype† MIRU type Spoligotypes
Deer 1 1997 SB0145 Not available   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Bovine 1 1998 SB0145 Not available   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Bovine 2 1999 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Bovine 3 1999 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Bovine 4 2002 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Human patient 1 2002 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Deer 2 2003 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Human patient 2 2004 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
Deer 3‡ 2004 SB0145 232224253322   Ɠ ƓƓƓƓƓƓƓƓƓƓ Ɠ                      ƓƓƓƓƓ 
*MIRU, mycobacterial interspersed repeat units (6). 
†International Spoligotype Database, available from www.mbovis.org (7). 
‡Deer shot by patient 2. Mycobacterium bovis Infection, Michigan
He continued to receive antimicrobial drug therapy for 9 
months without further complications
As an experienced hunter, patient 2 recognized the tan 
nodules in the deer’s chest cavity as M. bovis and promptly 
buried the carcass. In December, he led Michigan Depart-
ment of Natural Resources staff back to the carcass, which 
was retrieved; the chest cavity was ﬁ   lled with lesions 
(Figure). Although the carcass was buried for >9 weeks, 
chest cavity samples were submitted for culture. After nu-
merous attempts with alternative decontamination tech-
niques, a viable culture was obtained. Genotyping results 
of the carcass isolate were identical to that recovered from 
patient 2 and the circulating deer/cattle strain (Table 2). 
The investigation of the infection in patient 2 provided 
strong evidence of transmission of M. bovis infection from 
deer to human through percutaneous injection with a con-
taminated hunting knife. The patient’s history of hunting 
exposure was essential to diagnosis and treatment of this 
rare form of TB.
Conclusions
Although epidemiologic evidence presented for patient 
1 is not irrefutable, we conclude that both cases are part of 
a cluster that is epidemiologically and genotypically con-
ﬁ  rmed (11). The initial TST result was negative in both of 
these cases, likely due to cutaneous anergy (patient 1) and 
administration too soon after exposure (patient 2). Initial 
negative skin test results made diagnosis problematic for 
healthcare providers.
The conﬁ  rmation of a hunter’s acquiring cutaneous 
M. bovis from an infected deer supports the need for pub-
lic health precautions. First, hunters should wear heavy 
latex or rubber gloves while ﬁ   eld dressing deer. Sec-
ond, hunter education was important in the second case 
because the hunter recognized the deer as infected and 
speciﬁ  cally mentioned his exposure each time he sought 
medical treatment. Third, efforts to raise the index of sus-
picion of the medical community regarding cutaneous and 
other occupational or recreational exposures to TB con-
tinues to be important, so that appropriate diagnoses can 
be made. Finally, in both cases, the initially negative TST 
result complicated the diagnostic efforts. It is an ongoing 
challenge to ensure that providers appropriately apply and 
interpret the TST.
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